Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

E. P. Evdoshenko | Researchclopedia

Back to researchers

E. P. Evdoshenko

Multiple Sclerosis Foundation ORCID

52

Works

1,839

Citations

10

h-index

11

i10-index

Research Topics

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Polyomavirus and related diseases

Affiliations

Max Planck Society2019–2019

Multiple Sclerosis Foundation2025–2025

First Pavlov State Medical University of St. Petersburg2016–2017

Multiple Sclerosis Center of Atlanta2025–2025

City Clinical Hospital2019–2024

Top Works

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle,Giulio Disanto,et al.

2015294 citations

Long-Term Effects of COVID-19

Immunotherapy and Immune Responses

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid,Michelle Mellion,et al.

2019177 citations

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

Giulio Disanto,Rocco Adiutori,et al.

2015138 citations

Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis

Gleb Makshakov,В. Д. Назаров,et al.

201554 citations

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination

Marina Boziki,Alexios‐Fotios A. Mentis,et al.

202051 citations

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Gleb Makshakov,Е. П. Магонов,et al.

201749 citations

CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

Alexey A. Belogurov,К. А. Захаров,et al.

201637 citations

Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis

В. Д. Назаров,Gleb Makshakov,et al.

201812 citations

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population

E. P. Evdoshenko,Kristina Laskova,et al.

202110 citations